Trials / Completed
CompletedNCT03813121
The Effects of Sedatives on Tobacco Use Disorder
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Wake Forest University Health Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This proposal will obtain preliminary data on the effect of a single sub-anesthetic dose of a sedative on cigarette craving and smoking behavior as well as measuring tolerability and acceptability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | midazolam intravenous infusion | Participants will receive a single drug infusion |
| DRUG | placebo intravenous infusion | Participants will receive a single placebo infusion |
| DRUG | ketamine intravenous infusion | Participants will receive a single drug infusion |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2021-08-31
- Completion
- 2021-08-31
- First posted
- 2019-01-23
- Last updated
- 2022-10-06
- Results posted
- 2022-06-02
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03813121. Inclusion in this directory is not an endorsement.